nodes	percent_of_prediction	percent_of_DWPC	metapath
MACITENTAN—ALB—multiple sclerosis	0.456	1	CbGaD
MACITENTAN—ALB—Prednisone—multiple sclerosis	0.0662	0.172	CbGbCtD
MACITENTAN—CYP3A4—Fingolimod—multiple sclerosis	0.0531	0.138	CbGbCtD
MACITENTAN—CYP2C19—Prednisone—multiple sclerosis	0.0429	0.111	CbGbCtD
MACITENTAN—CYP3A4—Methylprednisolone—multiple sclerosis	0.0342	0.0889	CbGbCtD
MACITENTAN—ALB—Methotrexate—multiple sclerosis	0.0332	0.0862	CbGbCtD
MACITENTAN—CYP2C19—Dexamethasone—multiple sclerosis	0.0268	0.0695	CbGbCtD
MACITENTAN—CYP3A4—Triamcinolone—multiple sclerosis	0.026	0.0673	CbGbCtD
MACITENTAN—CYP3A4—Mitoxantrone—multiple sclerosis	0.025	0.0648	CbGbCtD
MACITENTAN—CYP3A4—Betamethasone—multiple sclerosis	0.0223	0.0578	CbGbCtD
MACITENTAN—CYP3A4—Prednisolone—multiple sclerosis	0.022	0.057	CbGbCtD
MACITENTAN—CYP3A4—Prednisone—multiple sclerosis	0.0207	0.0538	CbGbCtD
MACITENTAN—CYP3A4—Dexamethasone—multiple sclerosis	0.013	0.0336	CbGbCtD
MACITENTAN—Influenza—Fingolimod—multiple sclerosis	0.00239	0.0415	CcSEcCtD
MACITENTAN—Bronchitis—Fingolimod—multiple sclerosis	0.00229	0.0399	CcSEcCtD
MACITENTAN—Hepatotoxicity—Azathioprine—multiple sclerosis	0.00227	0.0394	CcSEcCtD
MACITENTAN—Infestation NOS—Fingolimod—multiple sclerosis	0.00213	0.037	CcSEcCtD
MACITENTAN—Infestation—Fingolimod—multiple sclerosis	0.00213	0.037	CcSEcCtD
MACITENTAN—Angiopathy—Fingolimod—multiple sclerosis	0.00173	0.0301	CcSEcCtD
MACITENTAN—Infection—Fingolimod—multiple sclerosis	0.00135	0.0234	CcSEcCtD
MACITENTAN—Nervous system disorder—Fingolimod—multiple sclerosis	0.00133	0.0231	CcSEcCtD
MACITENTAN—Hypotension—Fingolimod—multiple sclerosis	0.00127	0.022	CcSEcCtD
MACITENTAN—Infestation NOS—Cladribine—multiple sclerosis	0.00121	0.021	CcSEcCtD
MACITENTAN—Infestation—Cladribine—multiple sclerosis	0.00121	0.021	CcSEcCtD
MACITENTAN—Urinary tract infection—Cladribine—multiple sclerosis	0.00117	0.0204	CcSEcCtD
MACITENTAN—Fluid retention—Prednisolone—multiple sclerosis	0.0011	0.0192	CcSEcCtD
MACITENTAN—Pharyngitis—Cladribine—multiple sclerosis	0.00107	0.0187	CcSEcCtD
MACITENTAN—Fluid retention—Triamcinolone—multiple sclerosis	0.00101	0.0176	CcSEcCtD
MACITENTAN—Fluid retention—Methylprednisolone—multiple sclerosis	0.00101	0.0176	CcSEcCtD
MACITENTAN—Angiopathy—Cladribine—multiple sclerosis	0.000982	0.0171	CcSEcCtD
MACITENTAN—Infestation NOS—Azathioprine—multiple sclerosis	0.000981	0.017	CcSEcCtD
MACITENTAN—Infestation—Azathioprine—multiple sclerosis	0.000981	0.017	CcSEcCtD
MACITENTAN—Fluid retention—Betamethasone—multiple sclerosis	0.000921	0.016	CcSEcCtD
MACITENTAN—Fluid retention—Dexamethasone—multiple sclerosis	0.000921	0.016	CcSEcCtD
MACITENTAN—Hepatotoxicity—Methotrexate—multiple sclerosis	0.000914	0.0159	CcSEcCtD
MACITENTAN—Anaemia—Cladribine—multiple sclerosis	0.000871	0.0151	CcSEcCtD
MACITENTAN—Headache—Fingolimod—multiple sclerosis	0.00085	0.0148	CcSEcCtD
MACITENTAN—Fluid retention—Prednisone—multiple sclerosis	0.000802	0.0139	CcSEcCtD
MACITENTAN—Urinary tract infection—Mitoxantrone—multiple sclerosis	0.00077	0.0134	CcSEcCtD
MACITENTAN—Oedema—Cladribine—multiple sclerosis	0.000769	0.0134	CcSEcCtD
MACITENTAN—Infection—Cladribine—multiple sclerosis	0.000764	0.0133	CcSEcCtD
MACITENTAN—Nervous system disorder—Cladribine—multiple sclerosis	0.000754	0.0131	CcSEcCtD
MACITENTAN—Hypotension—Cladribine—multiple sclerosis	0.000719	0.0125	CcSEcCtD
MACITENTAN—Anaemia—Azathioprine—multiple sclerosis	0.000708	0.0123	CcSEcCtD
MACITENTAN—Pharyngitis—Mitoxantrone—multiple sclerosis	0.000706	0.0123	CcSEcCtD
MACITENTAN—Influenza—Triamcinolone—multiple sclerosis	0.000671	0.0117	CcSEcCtD
MACITENTAN—Bronchitis—Triamcinolone—multiple sclerosis	0.000645	0.0112	CcSEcCtD
MACITENTAN—Infection—Azathioprine—multiple sclerosis	0.000621	0.0108	CcSEcCtD
MACITENTAN—Infestation NOS—Methylprednisolone—multiple sclerosis	0.000597	0.0104	CcSEcCtD
MACITENTAN—Infestation—Methylprednisolone—multiple sclerosis	0.000597	0.0104	CcSEcCtD
MACITENTAN—Hypotension—Azathioprine—multiple sclerosis	0.000584	0.0102	CcSEcCtD
MACITENTAN—Anaemia—Mitoxantrone—multiple sclerosis	0.000573	0.00995	CcSEcCtD
MACITENTAN—Pharyngitis—Triamcinolone—multiple sclerosis	0.000533	0.00926	CcSEcCtD
MACITENTAN—Oedema—Mitoxantrone—multiple sclerosis	0.000506	0.00878	CcSEcCtD
MACITENTAN—Infection—Mitoxantrone—multiple sclerosis	0.000502	0.00873	CcSEcCtD
MACITENTAN—Angiopathy—Methylprednisolone—multiple sclerosis	0.000486	0.00844	CcSEcCtD
MACITENTAN—Headache—Cladribine—multiple sclerosis	0.000482	0.00837	CcSEcCtD
MACITENTAN—Hypotension—Mitoxantrone—multiple sclerosis	0.000472	0.00821	CcSEcCtD
MACITENTAN—Angiopathy—Dexamethasone—multiple sclerosis	0.000442	0.00768	CcSEcCtD
MACITENTAN—Angiopathy—Betamethasone—multiple sclerosis	0.000442	0.00768	CcSEcCtD
MACITENTAN—Oedema—Prednisolone—multiple sclerosis	0.000415	0.00721	CcSEcCtD
MACITENTAN—Infestation—Methotrexate—multiple sclerosis	0.000395	0.00686	CcSEcCtD
MACITENTAN—Infestation NOS—Methotrexate—multiple sclerosis	0.000395	0.00686	CcSEcCtD
MACITENTAN—Headache—Azathioprine—multiple sclerosis	0.000392	0.00681	CcSEcCtD
MACITENTAN—Angiopathy—Prednisone—multiple sclerosis	0.000385	0.00669	CcSEcCtD
MACITENTAN—Oedema—Triamcinolone—multiple sclerosis	0.000381	0.00663	CcSEcCtD
MACITENTAN—Infection—Triamcinolone—multiple sclerosis	0.000379	0.00658	CcSEcCtD
MACITENTAN—Infection—Methylprednisolone—multiple sclerosis	0.000378	0.00657	CcSEcCtD
MACITENTAN—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000373	0.00648	CcSEcCtD
MACITENTAN—Hypotension—Methylprednisolone—multiple sclerosis	0.000356	0.00618	CcSEcCtD
MACITENTAN—Pharyngitis—Methotrexate—multiple sclerosis	0.000352	0.00611	CcSEcCtD
MACITENTAN—Oedema—Betamethasone—multiple sclerosis	0.000346	0.00601	CcSEcCtD
MACITENTAN—Oedema—Dexamethasone—multiple sclerosis	0.000346	0.00601	CcSEcCtD
MACITENTAN—Infection—Betamethasone—multiple sclerosis	0.000344	0.00597	CcSEcCtD
MACITENTAN—Infection—Dexamethasone—multiple sclerosis	0.000344	0.00597	CcSEcCtD
MACITENTAN—Anaemia—Prednisone—multiple sclerosis	0.000341	0.00593	CcSEcCtD
MACITENTAN—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000339	0.0059	CcSEcCtD
MACITENTAN—Nervous system disorder—Betamethasone—multiple sclerosis	0.000339	0.0059	CcSEcCtD
MACITENTAN—Hypotension—Dexamethasone—multiple sclerosis	0.000323	0.00562	CcSEcCtD
MACITENTAN—Hypotension—Betamethasone—multiple sclerosis	0.000323	0.00562	CcSEcCtD
MACITENTAN—Angiopathy—Methotrexate—multiple sclerosis	0.000322	0.00559	CcSEcCtD
MACITENTAN—Headache—Mitoxantrone—multiple sclerosis	0.000317	0.0055	CcSEcCtD
MACITENTAN—Oedema—Prednisone—multiple sclerosis	0.000301	0.00524	CcSEcCtD
MACITENTAN—Infection—Prednisone—multiple sclerosis	0.000299	0.0052	CcSEcCtD
MACITENTAN—Nervous system disorder—Prednisone—multiple sclerosis	0.000296	0.00513	CcSEcCtD
MACITENTAN—Anaemia—Methotrexate—multiple sclerosis	0.000285	0.00496	CcSEcCtD
MACITENTAN—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000268	0.00267	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000265	0.00263	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—S1PR1—multiple sclerosis	0.000262	0.00261	CbGpPWpGaD
MACITENTAN—Headache—Prednisolone—multiple sclerosis	0.00026	0.00451	CcSEcCtD
MACITENTAN—EDNRA—GPCR ligand binding—PTGER4—multiple sclerosis	0.000258	0.00257	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—CCL5—multiple sclerosis	0.000256	0.00254	CbGpPWpGaD
MACITENTAN—Infection—Methotrexate—multiple sclerosis	0.00025	0.00435	CcSEcCtD
MACITENTAN—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—multiple sclerosis	0.00025	0.00248	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CXCR3—multiple sclerosis	0.00025	0.00248	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TAGAP—multiple sclerosis	0.000248	0.00246	CbGpPWpGaD
MACITENTAN—Nervous system disorder—Methotrexate—multiple sclerosis	0.000247	0.00429	CcSEcCtD
MACITENTAN—EDNRA—GPCR downstream signaling—RGS1—multiple sclerosis	0.000246	0.00244	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CCR2—multiple sclerosis	0.000243	0.00241	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—CCL5—multiple sclerosis	0.000243	0.00241	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00024	0.00238	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.000239	0.00238	CbGpPWpGaD
MACITENTAN—Headache—Triamcinolone—multiple sclerosis	0.000239	0.00415	CcSEcCtD
MACITENTAN—Headache—Methylprednisolone—multiple sclerosis	0.000238	0.00414	CcSEcCtD
MACITENTAN—Hypotension—Methotrexate—multiple sclerosis	0.000235	0.00409	CcSEcCtD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.000234	0.00233	CbGpPWpGaD
MACITENTAN—ALB—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000234	0.00233	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—GPR65—multiple sclerosis	0.000233	0.00231	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000228	0.00227	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000224	0.00223	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CNR1—multiple sclerosis	0.000224	0.00223	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—RGS1—multiple sclerosis	0.000223	0.00222	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00022	0.00218	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—CCR5—multiple sclerosis	0.000219	0.00217	CbGpPWpGaD
MACITENTAN—Headache—Dexamethasone—multiple sclerosis	0.000217	0.00377	CcSEcCtD
MACITENTAN—Headache—Betamethasone—multiple sclerosis	0.000217	0.00377	CcSEcCtD
MACITENTAN—EDNRB—Signaling Pathways—S1PR1—multiple sclerosis	0.000216	0.00215	CbGpPWpGaD
MACITENTAN—ALB—Lipid and lipoprotein metabolism—APOE—multiple sclerosis	0.000213	0.00212	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CCR1—multiple sclerosis	0.000213	0.00212	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000213	0.00212	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—GPR65—multiple sclerosis	0.000211	0.0021	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—GPC5—multiple sclerosis	0.000211	0.00209	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—APOE—multiple sclerosis	0.00021	0.00209	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000205	0.00204	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—LINGO1—multiple sclerosis	0.000204	0.00203	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000204	0.00203	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	0.000202	0.00201	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—IL4—multiple sclerosis	0.000202	0.00201	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CXCL10—multiple sclerosis	0.000202	0.00201	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000197	0.00196	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	0.000197	0.00196	CbGpPWpGaD
MACITENTAN—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000196	0.00195	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CXCL13—multiple sclerosis	0.000193	0.00192	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CCR1—multiple sclerosis	0.000193	0.00192	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000193	0.00192	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CCL3—multiple sclerosis	0.000193	0.00191	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CCR2—multiple sclerosis	0.000192	0.00191	CbGpPWpGaD
MACITENTAN—Headache—Prednisone—multiple sclerosis	0.000189	0.00328	CcSEcCtD
MACITENTAN—EDNRB—Signaling by GPCR—PTGER4—multiple sclerosis	0.000185	0.00184	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—RGS1—multiple sclerosis	0.000184	0.00183	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CXCR3—multiple sclerosis	0.000179	0.00178	CbGpPWpGaD
MACITENTAN—ALB—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000177	0.00176	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TAGAP—multiple sclerosis	0.000177	0.00176	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CNR1—multiple sclerosis	0.000177	0.00176	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—CCL2—multiple sclerosis	0.000176	0.00175	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—GPR65—multiple sclerosis	0.000174	0.00173	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CCR2—multiple sclerosis	0.000174	0.00173	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CCL5—multiple sclerosis	0.000174	0.00173	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000171	0.0017	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—POMC—multiple sclerosis	0.000171	0.0017	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—MERTK—multiple sclerosis	0.000169	0.00168	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—CD58—multiple sclerosis	0.000169	0.00168	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—SELPLG—multiple sclerosis	0.000169	0.00168	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—CCL2—multiple sclerosis	0.000167	0.00166	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000164	0.00163	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000164	0.00163	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000161	0.0016	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000161	0.0016	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CNR1—multiple sclerosis	0.000161	0.0016	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000161	0.0016	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—ICAM1—multiple sclerosis	0.00016	0.00159	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CCR1—multiple sclerosis	0.00016	0.00159	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CXCL13—multiple sclerosis	0.00016	0.00159	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000159	0.00158	CbGpPWpGaD
MACITENTAN—Headache—Methotrexate—multiple sclerosis	0.000158	0.00274	CcSEcCtD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000157	0.00156	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CCR5—multiple sclerosis	0.000156	0.00156	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—S1PR1—multiple sclerosis	0.000155	0.00154	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—GPC5—multiple sclerosis	0.000151	0.0015	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	0.00015	0.00149	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000146	0.00145	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CXCL10—multiple sclerosis	0.000145	0.00144	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—CCL2—multiple sclerosis	0.000143	0.00143	CbGpPWpGaD
MACITENTAN—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000142	0.00141	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000141	0.0014	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CCL3—multiple sclerosis	0.000138	0.00137	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CCR2—multiple sclerosis	0.000137	0.00136	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CCL5—multiple sclerosis	0.000137	0.00136	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	0.000134	0.00133	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—PTGER4—multiple sclerosis	0.000133	0.00132	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—RGS1—multiple sclerosis	0.000132	0.00131	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000132	0.00131	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CXCR3—multiple sclerosis	0.000128	0.00127	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000127	0.00127	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CNR1—multiple sclerosis	0.000127	0.00126	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—GPR65—multiple sclerosis	0.000125	0.00124	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CCR2—multiple sclerosis	0.000125	0.00124	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CCL5—multiple sclerosis	0.000125	0.00124	CbGpPWpGaD
MACITENTAN—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000124	0.00123	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CCR5—multiple sclerosis	0.000124	0.00123	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000123	0.00122	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—POMC—multiple sclerosis	0.000122	0.00122	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—IFNG—multiple sclerosis	0.000122	0.00121	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000122	0.00121	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CCL2—multiple sclerosis	0.00012	0.00119	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000119	0.00118	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000116	0.00116	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000116	0.00116	CbGpPWpGaD
MACITENTAN—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000115	0.00114	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CNR1—multiple sclerosis	0.000115	0.00114	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CCR1—multiple sclerosis	0.000114	0.00114	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CXCL13—multiple sclerosis	0.000114	0.00114	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000114	0.00113	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.000114	0.00113	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CCL3—multiple sclerosis	0.000114	0.00113	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CCR5—multiple sclerosis	0.000112	0.00112	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—IL2RA—multiple sclerosis	0.000111	0.0011	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PTGER4—multiple sclerosis	0.000109	0.00109	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—IL1B—multiple sclerosis	0.000109	0.00108	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—IL2—multiple sclerosis	0.000108	0.00108	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PGR—multiple sclerosis	0.000108	0.00107	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CXCR3—multiple sclerosis	0.000106	0.00105	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CD28—multiple sclerosis	0.000105	0.00104	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000104	0.00104	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000104	0.00104	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—PLEK—multiple sclerosis	0.000104	0.00104	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CXCL10—multiple sclerosis	0.000104	0.00103	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CCR2—multiple sclerosis	0.000103	0.00102	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CCL5—multiple sclerosis	9.81e-05	0.000976	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	9.7e-05	0.000965	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	9.69e-05	0.000963	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—POMC—multiple sclerosis	9.65e-05	0.00096	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CNR1—multiple sclerosis	9.49e-05	0.000944	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	9.42e-05	0.000937	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	9.02e-05	0.000896	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CCL5—multiple sclerosis	8.91e-05	0.000886	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CCR5—multiple sclerosis	8.84e-05	0.000879	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—POMC—multiple sclerosis	8.77e-05	0.000872	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—IL2RA—multiple sclerosis	8.71e-05	0.000866	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	8.64e-05	0.000859	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CCL2—multiple sclerosis	8.58e-05	0.000853	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CXCL10—multiple sclerosis	8.55e-05	0.00085	CbGpPWpGaD
MACITENTAN—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.54e-05	0.000849	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CCL3—multiple sclerosis	8.14e-05	0.000809	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CCR5—multiple sclerosis	8.03e-05	0.000798	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—IL2RA—multiple sclerosis	7.91e-05	0.000787	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—TNF—multiple sclerosis	7.89e-05	0.000785	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PTGER4—multiple sclerosis	7.83e-05	0.000779	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	7.83e-05	0.000779	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—TYK2—multiple sclerosis	7.79e-05	0.000775	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PGR—multiple sclerosis	7.72e-05	0.000767	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CXCR3—multiple sclerosis	7.57e-05	0.000752	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CD28—multiple sclerosis	7.5e-05	0.000745	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CD86—multiple sclerosis	7.47e-05	0.000743	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CCR2—multiple sclerosis	7.36e-05	0.000732	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CCL5—multiple sclerosis	7.36e-05	0.000731	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SRM—multiple sclerosis	7.35e-05	0.000731	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—SELE—multiple sclerosis	7.34e-05	0.00073	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—TGFB1—multiple sclerosis	7.25e-05	0.000721	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—IL2—multiple sclerosis	7.14e-05	0.00071	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.13e-05	0.000709	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	7.03e-05	0.000699	CbGpPWpGaD
MACITENTAN—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.92e-05	0.000688	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—POMC—multiple sclerosis	6.91e-05	0.000687	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	6.91e-05	0.000687	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—SPP1—multiple sclerosis	6.81e-05	0.000677	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CNR1—multiple sclerosis	6.79e-05	0.000675	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CCR5—multiple sclerosis	6.63e-05	0.000659	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SRM—multiple sclerosis	6.6e-05	0.000656	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IL2RA—multiple sclerosis	6.53e-05	0.000649	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—IL2—multiple sclerosis	6.48e-05	0.000644	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—IL6—multiple sclerosis	6.37e-05	0.000633	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.3e-05	0.000626	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—POMC—multiple sclerosis	6.27e-05	0.000624	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	6.27e-05	0.000624	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CCL2—multiple sclerosis	6.14e-05	0.00061	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—POMC—multiple sclerosis	6.12e-05	0.000608	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CXCL10—multiple sclerosis	6.12e-05	0.000608	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—APOE—multiple sclerosis	6.03e-05	0.000599	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—TYK2—multiple sclerosis	5.58e-05	0.000554	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CD80—multiple sclerosis	5.45e-05	0.000542	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CD86—multiple sclerosis	5.35e-05	0.000532	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—ITGA4—multiple sclerosis	5.31e-05	0.000527	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—IFNB1—multiple sclerosis	5.27e-05	0.000524	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CCL5—multiple sclerosis	5.26e-05	0.000523	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CYP27B1—multiple sclerosis	5.18e-05	0.000515	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CYP24A1—multiple sclerosis	5.18e-05	0.000515	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—POMC—multiple sclerosis	5.18e-05	0.000515	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—IL2—multiple sclerosis	5.11e-05	0.000508	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CCL2—multiple sclerosis	5.07e-05	0.000504	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.06e-05	0.000503	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	5.06e-05	0.000503	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—MAPK1—multiple sclerosis	4.96e-05	0.000493	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—SPP1—multiple sclerosis	4.88e-05	0.000485	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CCR5—multiple sclerosis	4.74e-05	0.000472	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GPC5—multiple sclerosis	4.74e-05	0.000471	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IL2RA—multiple sclerosis	4.67e-05	0.000465	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	4.65e-05	0.000462	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	4.65e-05	0.000462	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—IL2—multiple sclerosis	4.64e-05	0.000461	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TYK2—multiple sclerosis	4.6e-05	0.000458	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.54e-05	0.000452	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—APOE—multiple sclerosis	4.32e-05	0.000429	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GPC5—multiple sclerosis	4.25e-05	0.000423	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	4.12e-05	0.00041	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SRM—multiple sclerosis	3.97e-05	0.000395	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—RRM1—multiple sclerosis	3.93e-05	0.00039	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CD80—multiple sclerosis	3.9e-05	0.000388	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IL2—multiple sclerosis	3.83e-05	0.000381	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—IL6—multiple sclerosis	3.81e-05	0.000379	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—POMC—multiple sclerosis	3.71e-05	0.000369	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.68e-05	0.000366	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CCL2—multiple sclerosis	3.63e-05	0.000361	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—IL2RA—multiple sclerosis	3.62e-05	0.00036	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MMP9—multiple sclerosis	3.62e-05	0.00036	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—MAPK1—multiple sclerosis	3.55e-05	0.000353	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—RRM1—multiple sclerosis	3.52e-05	0.00035	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TYK2—multiple sclerosis	3.29e-05	0.000327	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—STAT3—multiple sclerosis	3.22e-05	0.00032	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	3.22e-05	0.00032	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	3.15e-05	0.000313	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.05e-05	0.000303	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MYC—multiple sclerosis	2.99e-05	0.000298	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TGFB1—multiple sclerosis	2.99e-05	0.000297	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MAPK1—multiple sclerosis	2.93e-05	0.000291	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.8e-05	0.000278	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.8e-05	0.000278	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IL2—multiple sclerosis	2.74e-05	0.000272	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.73e-05	0.000272	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—IL6—multiple sclerosis	2.73e-05	0.000271	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.62e-05	0.00026	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MMP9—multiple sclerosis	2.59e-05	0.000258	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.56e-05	0.000254	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.35e-05	0.000234	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—STAT3—multiple sclerosis	2.31e-05	0.000229	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—BCHE—multiple sclerosis	2.25e-05	0.000224	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IL6—multiple sclerosis	2.25e-05	0.000224	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MYC—multiple sclerosis	2.14e-05	0.000213	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.14e-05	0.000213	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TGFB1—multiple sclerosis	2.14e-05	0.000213	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—IL2—multiple sclerosis	2.12e-05	0.000211	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.12e-05	0.000211	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MAPK1—multiple sclerosis	2.1e-05	0.000208	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—BCHE—multiple sclerosis	2.02e-05	0.000201	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—TGFB1—multiple sclerosis	1.66e-05	0.000165	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—MAPK1—multiple sclerosis	1.63e-05	0.000162	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IL6—multiple sclerosis	1.61e-05	0.00016	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—APOE—multiple sclerosis	1.36e-05	0.000135	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—APOE—multiple sclerosis	1.22e-05	0.000121	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.22e-05	0.000121	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—POMC—multiple sclerosis	1.17e-05	0.000116	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—POMC—multiple sclerosis	1.05e-05	0.000104	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ALB—multiple sclerosis	9.54e-06	9.48e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—APOE—multiple sclerosis	7.32e-06	7.28e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—POMC—multiple sclerosis	6.29e-06	6.25e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ALB—multiple sclerosis	5.73e-06	5.7e-05	CbGpPWpGaD
